See How ENBREL Helped
Phil Mickelson Stay On Course

We are lucky in life when we can pursue our passion, as I've been able to do in my career. Every day I'm thankful that I can play golf and spend quality time with my wife and my three children. But last year my life as I knew it was suddenly turned upside down when I began experiencing joint stiffness and severe pain.

In the months leading up to the 2010 U.S. Open, I developed pain near my ankle that made it difficult to walk, and my left index finger and right wrist felt as if they were sprained. At first, I thought these aches could be caused by years of practicing and playing golf and that they would eventually pass. Then, after two days of preparing for the U.S. Open, I awoke and the pain in my joints was so intense I could hardly get out of bed.

Phil Mickelson talks about ENBREL

Phil Mickelson, Champion golfer and ENBREL PsA patient since 2010

Once I saw my rheumatologist and received the information I needed, I felt empowered and confident that together we would find the right treatment to manage my condition.
With the support of my loved ones, I decided to act quickly and educate myself about my symptoms. I found a rheumatologist who was able to provide me with some answers as to why I was feeling so badly. In the week following the U.S. Open, I was diagnosed with psoriatic arthritis.

Once I saw my rheumatologist and received the information I needed to understand my symptoms, learn my diagnosis and make an informed decision for me about my treatment options, I felt empowered and confident that together we would find the right treatment to manage my condition. Since then, I have been diligent about taking my treatment and have followed my rheumatologist's recommendations to improve my overall health to help me stay "On Course" both professionally and at home. I've continued to play golf and have been able to keep doing fun things with my family, like playing catch or going for a swim or a hike. I feel good!

Sincerely,

Phil Mickelson
Phil Mickelson

Results may vary.




Important Safety Information Prescribing Information Medication Guide
Indications
 
Moderate to Severe Rheumatoid Arthritis Supportive Data Psoriatic Arthritis Supportive Data
Safety Information ISI

ENBREL for psoriatic arthritis

Patients on ENBREL achieved substantial skin clearing.

View clinical efficacy in psoriatic arthritis

ENBREL is
efficacious across three measures

In patients with moderate to severe early RA, ENBREL has shown to reduce signs and symptoms, inhibit the progression of structural damage, and improve physical function.

View clinical efficacy in RA
 
 
Close
You are leaving Enbrel.com/RheumPro
Please know that Amgen and Pfizer do not endorse and are not responsible for the content included on the site you are about to enter. Click the "Continue" button to proceed.

To return to ENBREL.com, click "Cancel" or close this window.

Privacy Policy  Terms of Use
This site is intended for US Audiences only.
©2011 Amgen, Inc., Thousand Oaks, CA 91320 and Pfizer Inc
Close
E-mail this page to a colleague
Please correct the fields marked in red
Send
This content is for US health care professionals only. Amgen and Pfizer will not use your e-mail address or your colleague's e-mail address for any other purpose. To learn more about our use of your information and your rights, please consult our Privacy Policy.
Close

Send another e-mail
Return to enbrel.com/RheumPro

Close
Notice

The following information is intended for use only by residents of the United States. Countries outside of the United States may have regulatory requirements or medical practices that are different than those in the United States and may require reference to different or additional information. Therefore, this information may not be appropriate outside of the United States.

If you are a resident of the United States or one of its territories, or a health care professional practicing your profession in the United States or one of its territories, please click below.

If you are a resident of a country other than the United States, please visit the Pfizer website and the Amgen website to find information about our offices around the globe.
Close
Disease activity vs. structural progression in RA